|
Dechra Pharmaceuticals PLC - veterinary drug maker - Says private equity takeover approved at court and general meeting. Dechra says holders of 99% of scheme shares voted in favour at a court meeting. At a general meeting, 99% also backed it. Dechra in June agreed to a downwardly adjusted takeover by EQT AB, which is a Swedish private equity firm, and Luxinva SA, which is controlled by the sovereign wealth fund of the United Arab Emirates. The offer values Dechra at £4.46 billion on a fully-diluted basis and gives an enterprise value of £4.88 billion. Current stock price: 3,716.00 pence 12-month change: up 2.7% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
